Biofil Chemicals & Pharmaceuticals Ltd Share Price

Pharmaceuticals - Indian - Formulations

NSE: BIOFILCHEM Small Cap ISIN: INE829A01014

As on 31 January 2025 at 14:09 IST

₹55.63

+ 2.82

(5.34%)

Sell Buy

Over 1 Month

-7.33%

Over 6 Months

-21.36%

Over 1 Year

-25.15%

Over 3 Years

-32.38%

Biofil Chemicals & Pharmaceuticals Ltd Summary

Close ₹ 55.63

Open ₹ 53.19

High ₹ 56.44

Low ₹ 53.19

Volume 14,291

Net Turnover (in ₹ Cr) ₹ 0.063

52Wk High ₹ 91.87

52Wk Low ₹ 49.05

52Wk High / Low

49.05

91.87

Biofil Chemicals & Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 85.92

EPS (TTM) 0.33

Book Value (BV) 11.30

Div. Yield -

P/E (TTM) 160.82

Price/Book Value 4.69

Delivery % 66.82 %

Face Value 10

Key Ratios

PE Ratio 137.18

PB Ratio 5.39

EV to Sales 2.41

PEG Ratio 4.66

ROA 3.81

ROE 1.42

Debt-Equity 0.03

Net Profit Margin 1.77

Operating Profit Margin 3.25

Biofil Chemicals & Pharmaceuticals Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

No data available

Balance Sheet

No data available

Cash Flow

No data available

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	40.52	30.13	22.53	36.55	29.86
Total Expenses	39.66	29.34	21.52	34.63	28.40
Profit Before Tax	0.87	0.79	1.01	1.92	1.46
Profit After Tax	0.71	0.56	0.70	1.24	1.21
Operating Profit after Depreciation	0.91	0.84	1.06	1.99	1.59

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	8.62	9	9.42	9.78	10.09
Total Non Current Assets	8.68	9.05	9.42	9.78	10.09
Total Current Assets	38.41	22.35	9.31	23.46	32.27
TOTAL ASSETS	47.08	31.41	18.73	33.24	42.36
Total Shareholder's Fund	18.20	17.30	16.84	16.13	14.88

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	2.39	-0.11	-0.22	1.11	0.89
Net Cash used in Investing Activities	-0.02	-0.01	-0.07	-0.10	-0.21
Net Cash used in Financing Activities	-0.12	0.02	-0.01	-0.83	-0.57

No data available

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	2.41	8.44	15.20	5.03	17.37
Total Expenses	2.29	8.13	15.23	4.84	17.13
Profit Before Tax	0.03	0.23	0.28	0.11	0.15
Profit After Tax	0.02	0.17	0.25	0.09	0.12
Operating Profit after Depreciation	0.14	0.34	0.38	0.22	0.27

Biofil Chemicals & Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 51.72

S2 50.63

S3 49.75

Pivot 52.60

R1 53.69

R2 54.57

R3 55.66

Moving Average

20 SMA 55.51

50 SMA 59.54

100 SMA 65.64

200 SMA 65.60

Biofil Chemicals & Pharmaceuticals Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

AGM Date: 30 Sep 2022

With reference to the above-mentioned subject and as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of the Directors of the Company in their meeting (No. 02/2022-2023) held on today i.e. Tuesday, 9th August 2022, has inter alia approved matters along with other routine businesses Pursuant to the provisions of the Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, read with Section 91 of the Companies Act 2013 the Register of Members and Share Transfer Books of the Company shall be remain closed as per attached (As per BSE Announcement Dated on 3/9/2022) Summary of Proceedings of 37th Annual General Meeting of the Company held on Friday, 30th September, 2022 pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015 (As Per BSE Announcement dated on 30.09.2022) Submission of Voting Results and Combined Scrutinizer's Report on Remote E-voting and e-voting facility during the 37th Annual General Meeting of the Company. (As Per BSE Announcement Dated 01.10.2022)

AGM Date: 27 Sep 2023

With Reference with the above captioned subject and in terms of Regulation 47 of SEBI (LODR) Regulations, 2015, Please find enclosed herewith the public notice published on 24th August, 2023 in newspaper i.e. Free Press, Mumbai and Indore (In English) and Choutha Sansar (In Hindi) regarding information of 38th Annual General Meeting to be held through Video Conferencing/ other audio visual means. With reference to subject captioned above, please find enclosed herewith the Notice convening 38th Annual General Meeting of the Company scheduled to be held on Wednesday, 27th September, 2023 at 03:00 P.M. (IST) through Video Conferencing ('VC')/ Other Audio Visual Means ('OAVM') for which purpose the Registered Office of the Company shall be deemed as the venue for the Meeting. Further, we are submitting the above said information in XBRL mode along with submission in PDF mode. You are requested to please take on record the above Notice of 38th Annual General Meeting for your reference and further needful. (As Per BSE Announcement dated on 02.09.2023) Summary of proceedings of 38th Annual General Meeting of the Company held on Wednesday, 27th September, 2023 pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (LODR), Regulations, 2015. (As Per BSE Announcement dated on 27.09.2023) Submission of Combined Scrutinizer''s Report on remote e-voting and e-voting facility during 38th Annual General Meeting of the Company. (As Per BSE Announcement Dated on 29/09/2023)

AGM Date: 30 Sep 2024

Newspaper publication regarding intimation of AGM of the COmpany scheduled to be held on 30th September 2024 and informing shareholders manner of registration of email Combined Scrutinizer report alongwith voting results for AGM (As per BSE Announcement Dated on 1/10/2024)

Biofil Chemicals & Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Biofil Chemicals & Pharmaceuticals Ltd	₹53.07	₹86.34
Sun Pharmaceuticals Industries Ltd	₹1,745.25	₹4,18,743.94
Divis Laboratories Ltd	₹5,733.60	₹1,52,209.07
Cipla Ltd	₹1,458.15	₹1,17,762.24
Torrent Pharmaceuticals Ltd	₹3,357.15	₹1,13,616.11
Mankind Pharma Ltd	₹2,488.40	₹1,02,663.15

Biofil Chemicals & Pharmaceuticals Ltd News

Biofil Chemicals & Pharmaceuticals to conduct board meeting

On 14 November 2024

08 Nov 2024, 04:59 pm

Biofil Chemicals & Pharmaceuticals AGM scheduled

On 30 September 2024

10 Sep 2024, 05:35 pm

Biofil Chemicals & Pharmaceuticals to table results

On 13 August 2024

12 Aug 2024, 02:18 pm

Biofil Chemicals & Pharmaceuticals schedules board meeting

On 30 May 2024

27 May 2024, 11:24 am

Biofil Chemicals & Pharmaceuticals to declare Quarterly Result

On 6 February 2024

31 Jan 2024, 02:13 pm

Biofil Chemicals & Pharmaceuticals Ltd Stock Analysis

Annual revenue for Biofil Chemicals & Pharmaceuticals Ltd increased by 34.49% to ₹40.52 crore in FY 2024 from ₹30.13 crore in FY 2023.
Annual Net Profit for Biofil Chemicals & Pharmaceuticals Ltd increased by 26.55% to ₹0.71 crore in FY 2024 from ₹0.56 crore in FY 2023.
Promoter Shareholding in Biofil Chemicals & Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 46.82% in September 2024 to 46.82% in December 2024.
Biofil Chemicals & Pharmaceuticals Ltd delivered a 1-year return of -25.15% compared to the Nifty 50, which provided a return of 8.03% as of the last trading session.
Biofil Chemicals & Pharmaceuticals Ltd share price moved up by 5.34% from its previous close of INR ₹52.81. The latest Biofil Chemicals & Pharmaceuticals Ltd share price is INR ₹55.63.
Biofil Chemicals & Pharmaceuticals Ltd share price today has been at a low of 53.19 and a high of 56.44. Over the past 52 weeks, the Biofil Chemicals & Pharmaceuticals Ltd share price has seen a low of 49.05 and a high of 91.87.